Figures & data
Table 1. Post-natal day 22 (PND22) mouse liver samples (n = 147) and 10-month mouse liver samples (n = 78) for bisulfite sequencing
Table 2. Candidate gene regions for bisulfite sequencing
Figure 1. Stat3 methylation in 10-month mouse livers by dose and tumor status. (A) Average percent DNA methylation at Stat3 by dose group in 10-month mice perinatally exposed to 50 ng (n = 20), 50 µg (n = 21) or 50 mg (n = 18) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 19). (B) Percent DNA methylation at Stat3 by tumor status in 10-month mice perinatally exposed to 50 ng (n = 20), 50 µg (n = 21) or 50 mg (n = 18) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 19). *P <0.1, **P<0.05
![Figure 1. Stat3 methylation in 10-month mouse livers by dose and tumor status. (A) Average percent DNA methylation at Stat3 by dose group in 10-month mice perinatally exposed to 50 ng (n = 20), 50 µg (n = 21) or 50 mg (n = 18) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 19). (B) Percent DNA methylation at Stat3 by tumor status in 10-month mice perinatally exposed to 50 ng (n = 20), 50 µg (n = 21) or 50 mg (n = 18) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 19). *P <0.1, **P<0.05](/cms/asset/dd01e721-b06a-4cbc-9032-3deae2a80981/kepi_a_1107694_f0001_oc.gif)
Figure 2. Site-specific Stat3 methylation in 10-month mouse livers by dose. (A) Average percent DNA methylation at Stat3 by dose group in 10-month mice perinatally exposed to 50 ng (n = 20), 50 µg (n = 21) or 50 mg (n = 18) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 19). is the same as . These data are repeated for ease of comparison by the reader. (B) Percent DNA methylation at Stat3 by CpG site in 10-month mice perinatally exposed to 50 ng (n = 20), 50 µg (n = 21) or 50 mg (n = 18) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 19). *P < 0.1, **P < 0.05.
![Figure 2. Site-specific Stat3 methylation in 10-month mouse livers by dose. (A) Average percent DNA methylation at Stat3 by dose group in 10-month mice perinatally exposed to 50 ng (n = 20), 50 µg (n = 21) or 50 mg (n = 18) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 19). Figure 1A is the same as Figure 2A. These data are repeated for ease of comparison by the reader. (B) Percent DNA methylation at Stat3 by CpG site in 10-month mice perinatally exposed to 50 ng (n = 20), 50 µg (n = 21) or 50 mg (n = 18) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 19). *P < 0.1, **P < 0.05.](/cms/asset/87e4cea3-2303-4037-b18f-ac34293f0ea4/kepi_a_1107694_f0002_oc.gif)
Figure 3. Site-specific Stat3 methylation in PND22 mouse livers by dose. (A) Average percent DNA methylation at Stat3 by dose group in post-natal day 22 (PND22) mice perinatally exposed to 50 ng (n = 48), 50 µg (n = 22) or 50 mg (n = 40) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 37). is the same as . These data are repeated for ease of comparison by the reader. (B) Percent DNA methylation at Stat3 by CpG site in PND22 mice perinatally exposed to 50 ng (n = 48), 50 µg (n = 22) or 50 mg (n = 40) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 37). *P < 0.1, **P < 0.05.
![Figure 3. Site-specific Stat3 methylation in PND22 mouse livers by dose. (A) Average percent DNA methylation at Stat3 by dose group in post-natal day 22 (PND22) mice perinatally exposed to 50 ng (n = 48), 50 µg (n = 22) or 50 mg (n = 40) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 37). Figure 2A is the same as Figure 1A. These data are repeated for ease of comparison by the reader. (B) Percent DNA methylation at Stat3 by CpG site in PND22 mice perinatally exposed to 50 ng (n = 48), 50 µg (n = 22) or 50 mg (n = 40) BPA/kg maternal diet or a phytoestrogen-free control diet (n = 37). *P < 0.1, **P < 0.05.](/cms/asset/62e24c20-6048-4b8a-b1cd-7c64adcb5450/kepi_a_1107694_f0003_oc.gif)
Figure 4. STAT3 methylation in human fetal livers by continuous total BPA. Average percent DNA methylation at STAT3 by dose group in human fetal liver samples (n = 50) by continuous liver tissue total BPA.
![Figure 4. STAT3 methylation in human fetal livers by continuous total BPA. Average percent DNA methylation at STAT3 by dose group in human fetal liver samples (n = 50) by continuous liver tissue total BPA.](/cms/asset/98b0d2d3-f2b0-45fe-b386-353b532ae880/kepi_a_1107694_f0004_oc.gif)
Figure 5. STAT3 methylation in human fetal livers by continuous free BPA. Average percent DNA methylation at STAT3 by dose group in human fetal liver samples (n = 50) by continuous liver tissue free BPA.
![Figure 5. STAT3 methylation in human fetal livers by continuous free BPA. Average percent DNA methylation at STAT3 by dose group in human fetal liver samples (n = 50) by continuous liver tissue free BPA.](/cms/asset/011c126d-c333-41bd-9162-1bb7d07b0083/kepi_a_1107694_f0005_oc.gif)
Table 3. Primer sets for bisulfite sequencing.
Table 4. Primer sets for mRNA expression analysis for Stat3, STAT3, and reference genes via qPCR.